The Juliette S, Schilling Kathy J, Hoffmeister Jeffrey W, Friedmann Euvondia, McGinnis Ryan, Holcomb Richard G
Center for Breast Care, Boca Raton Community Hospital, Boca Raton, FL 33486, USA.
AJR Am J Roentgenol. 2009 Feb;192(2):337-40. doi: 10.2214/AJR.07.3884.
The purpose of this study was to evaluate computer-aided detection (CAD) performance with full-field digital mammography (FFDM).
CAD (Second Look, version 7.2) was used to evaluate 123 cases of breast cancer detected with FFDM (Senographe DS). Retrospectively, CAD sensitivity was assessed using breast density, mammographic presentation, histopathology results, and lesion size. To determine the case-based false-positive rate, patients with four standard views per case were included in the study group. Eighteen unilateral mammography examinations with nonstandard views were excluded, resulting in a sample of 105 bilateral cases.
CAD detected 115 (94%) of 123 cancer cases: six of six (100%) in fatty breasts, 63 of 66 (95%) in breasts containing scattered fibroglandular densities, 43 of 46 (93%) in heterogeneously dense breasts, and three of five (60%) in extremely dense breasts. CAD detected 93% (41/44) of cancers manifesting as calcifications, 92% (57/62) as masses, and 100% (17/17) as mixed masses and calcifications. CAD detected 94% of the invasive ductal carcinomas (n = 63), 100% of the invasive lobular carcinomas (n = 7), 91% of the other invasive carcinomas (n = 11), and 93% of the ductal carcinomas in situ (n = 42). CAD sensitivity for cancers 1-10 mm (n = 55) was 89%; 11-20 mm (n = 37), 97%; 21-30 mm (n = 16), 100%; and larger than 30 mm (n = 15), 93%. The CAD false-positive rate was 2.3 marks per four-image case.
CAD with FFDM showed a high sensitivity in identifying cancers manifesting as calcifications and masses. Sensitivity was maintained in cancers with lower mammographic sensitivity, including invasive lobular carcinomas and small neoplasms (1-20 mm). CAD with FFDM should be effective in assisting radiologists with earlier detection of breast cancer. Future studies are needed to assess CAD accuracy in larger populations.
本研究旨在评估全视野数字乳腺摄影(FFDM)中计算机辅助检测(CAD)的性能。
使用CAD(Second Look,版本7.2)评估123例经FFDM(Senographe DS)检测出的乳腺癌病例。回顾性地,根据乳腺密度、乳腺X线表现、组织病理学结果和病变大小评估CAD的敏感性。为确定基于病例的假阳性率,研究组纳入每例有四张标准视图的患者。排除18例非标准视图的单侧乳腺摄影检查,得到105例双侧病例的样本。
CAD检测出123例癌症病例中的115例(94%):脂肪型乳腺中的6例(100%)全部被检测出,含散在纤维腺密度的乳腺中的66例中有63例(95%)被检测出,不均匀致密型乳腺中的46例中有43例(93%)被检测出,极度致密型乳腺中的5例中有3例(60%)被检测出。CAD检测出表现为钙化的癌症中的93%(41/44)、表现为肿块的癌症中的92%(57/62)以及表现为混合性肿块和钙化的癌症中的100%(17/17)。CAD检测出浸润性导管癌(n = 63)中的94%、浸润性小叶癌(n = 7)中的100%、其他浸润性癌(n = 11)中的91%以及导管原位癌(n = 42)中的93%。CAD对1 - 10毫米(n = 55)的癌症的敏感性为89%;对11 - 20毫米(n = 37)的癌症的敏感性为97%;对21 - 30毫米(n = 16)的癌症的敏感性为100%;对大于30毫米(n = 15)的癌症的敏感性为93%。CAD的假阳性率为每四张图像病例2.3个标记。
FFDM联合CAD在识别表现为钙化和肿块的癌症方面显示出高敏感性。在乳腺X线敏感性较低的癌症中,包括浸润性小叶癌和小肿瘤(1 - 20毫米),敏感性得以保持。FFDM联合CAD应能有效协助放射科医生更早地检测出乳腺癌。未来需要进行研究以评估更大人群中CAD的准确性。